Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
12,130
+274
+2% +$32.1K 0.84% 29
2026
Q1
$1.43M Buy
11,856
+1,268
+12% +$146K 0.95% 27
2025
Q4
$1.11M Sell
10,588
-275
-3% -$25.8K 0.77% 34
2025
Q3
$912K Sell
10,863
-160
-1% -$13.2K 0.63% 43
2025
Q2
$873K Sell
11,023
-40
-0.4% -$3.18K 0.7% 43
2025
Q1
$993K Buy
11,063
+1,719
+18% +$160K 0.94% 38
2024
Q4
$930K Buy
+9,344
New +$963K 0.95% 37

Other funds holding MRK

WinCap Financial's MRK Position: Q2 2026 in Review

WinCap Financial increased its Merck (MRK) stake by 2.3% in Q2 2026, buying an estimated $32.1K and bringing the position to 12,130 shares worth $1.56M. The position accounts for 0.84% of the portfolio, ranked #29.

WinCap Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • WinCap Financial held 12,130 shares of Merck worth $1.56M as of Q2 2026.
  • WinCap Financial bought 274 Merck shares in Q2 2026, an estimated $32.1K.
  • Merck made up 0.84% of WinCap Financial's portfolio in Q2 2026, its #29 holding.
  • WinCap Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on WinCap Financial's 13F filing for Q2 2026, filed 9 Jul 2026.